tiprankstipranks
Trending News
More News >
Advertisement

TOUS - ETF AI Analysis

Compare

Top Page

TOUS

T. Rowe Price International Equity ETF (TOUS)

Rating:65Neutral
Price Target:
TOUS, the T. Rowe Price International Equity ETF, has a solid overall rating driven mainly by strong, well-established holdings like AstraZeneca, ASML, and Barclays, which show robust financial performance, positive earnings calls, and generally supportive technical trends. These strengths are balanced by weaker spots such as Renesas Electronics, where declining revenue and profitability create some drag, and by risks like high valuations or financial stability concerns in a few names, which can add volatility even though the fund is diversified across multiple international sectors and regions.
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries in Europe, Asia, and North America, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across financials, industrials, technology, health care, and several other sectors, limiting reliance on any one part of the economy.
Supportive Asset Base and Recent Performance
The ETF manages over a billion dollars and has shown steady gains over the past month, three months, and year-to-date, suggesting healthy investor interest and recent momentum.
Negative Factors
Moderate Expense Ratio
The fund’s fee is higher than many low-cost index ETFs, which can slightly reduce long-term returns for buy-and-hold investors.
Concentration in Financials and Industrials
A large share of assets is in financial and industrial companies, which could hurt performance if these sectors face a downturn.
Mixed Performance Among Top Holdings
While some leading positions have delivered strong gains, others have been weak or slightly negative this year, creating uneven contribution to returns.

TOUS vs. SPDR S&P 500 ETF (SPY)

TOUS Summary

The T. Rowe Price International Equity ETF (TOUS) is an actively managed fund that invests in stocks from many countries outside the U.S., aiming to capture the total international market rather than tracking a specific index. It holds companies from Japan, the UK, Europe, and more, across sectors like financials, industrials, and technology. Well-known holdings include ASML Holding and Unilever. Someone might invest in TOUS to diversify beyond U.S. stocks and tap into growth in both developed and emerging markets. A key risk is that international stocks can be volatile and are affected by currency swings and global economic conditions.
How much will it cost me?The T. Rowe Price International Equity ETF (TOUS) has an expense ratio of 0.5%, which means you’ll pay $5 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers are selecting investments rather than tracking a passive index.
What would affect this ETF?The T. Rowe Price International Equity ETF (TOUS) could benefit from growth in developed markets outside the U.S., particularly in sectors like financials, technology, and health care, which make up a significant portion of its holdings. However, potential risks include economic slowdowns in key regions, regulatory changes affecting top holdings like ASML or AstraZeneca, and currency fluctuations that could impact returns for U.S.-based investors. Global interest rate changes and geopolitical tensions may also influence the ETF's performance.

TOUS Top 10 Holdings

TOUS leans heavily on non-U.S. financials and industrials, with banks like Mitsubishi UFJ, UniCredit, and Barclays quietly powering recent gains as they ride improving profitability and upbeat outlooks. ASML and Renesas add a tech edge, with ASML in particular acting as a key growth engine, while Rolls-Royce and Siemens keep the industrial side humming. On the defensive front, AstraZeneca and especially Unilever have been more of a speed bump, with softer momentum. Overall, it’s a developed-markets ex-U.S. story, tilted toward Europe and Japan.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.51%$43.56M€464.34B67.81%
76
Outperform
AstraZeneca2.46%$30.54M$288.71B29.97%
79
Outperform
Rolls-Royce Holdings1.98%$24.58M£102.13B124.42%
71
Outperform
UniCredit SpA1.91%$23.67M€114.41B85.13%
75
Outperform
Roche Holding AG1.54%$19.15MCHF279.83B49.72%
73
Outperform
Renesas Electronics1.43%$17.80M¥4.58T22.49%
64
Neutral
Siemens1.40%$17.39M€199.98B24.44%
74
Outperform
Unilever1.30%$16.14M£107.74B-5.19%
72
Outperform
Barclays1.27%$15.76M£67.09B62.14%
78
Outperform
Mitsubishi UFJ Financial Group1.20%$14.90M¥31.36T41.66%
76
Outperform

TOUS Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
34.59
Positive
100DMA
33.87
Positive
200DMA
32.53
Positive
Market Momentum
MACD
0.54
Negative
RSI
63.11
Neutral
STOCH
61.35
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TOUS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.84, equal to the 50-day MA of 34.59, and equal to the 200-day MA of 32.53, indicating a bullish trend. The MACD of 0.54 indicates Negative momentum. The RSI at 63.11 is Neutral, neither overbought nor oversold. The STOCH value of 61.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TOUS.

TOUS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.24B0.50%
$5.41B0.28%
$5.28B0.39%
$4.52B0.42%
$1.76B0.54%
$1.01B0.24%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TOUS
T. Rowe Price International Equity ETF
36.37
9.20
33.86%
DIHP
Dimensional International High Profitability ETF
DFIS
Dimensional International Small Cap ETF
DISV
Dimensional International Small Cap Value ETF
CGIE
Capital Group International Equity ETF
DFSI
Dimensional International Sustainability Core 1 ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement